Project

Project details

  • TITLE

    Evaluating the efficacy of Ocrelizumab in Primary PrOgRessive mulTiple sclerosis: a mUlticeNter retrospectIve sTudY (OPPORTUNITY).

  • SYNOPSIS AND RESULTS

  • Data start Data end
    2020-10-12 2023-12-31
  • PARTICIPATING CENTERS

    ---

  • OUTCOME

    ---

  • PUBLICATIONS

    ---

Privacy Policy

Fondazione Italiana Sclerosi Multipla – FISM – Ente del Terzo Settore/ETS e, in forma abbreviata, FISM ETS.
Iscrizione al RUNTS Rep. N° 89695 - Fondazione con Riconoscimento di Personalità Giuridica - C.F. 95051730109